FDA Approves Once-Monthly Hereditary Angioedema Drug

(MedPage Today) — Anti-factor XIIa biologic garadacimab (Andembry) got the FDA greenlight for use in preventing hereditary angioedema (HAE) attacks in adult and pediatric patients ages 12 years and older, CSL announced.
Garadacimab is the only…

Source link : https://www.medpagetoday.com/washington-watch/fdageneral/116122

Author :

Publish date : 2025-06-17 20:32:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

FDA Approves Once-Monthly Hereditary Angioedema Drug

Could reusable rockets make solar geoengineering less risky?

Patient Safety Network Papers Restored Amid Lawsuit From Doctors

Related Posts

‘My dad started spying on my mum’ – the drugs causing sexual urges

10,000 steps myth – should you be a stickler for recommended daily doses?

Why we need to talk about periods, breasts and injuries

Solar drone with wingspan wider than jumbo jet could fly for months

Study Touts Benefit of Mini Nonhormonal IUD — But It’s Not Sold in the U.S.

Negative social ties, like frenemies, could be ageing you

‘My dad started spying on my mum’ – the drugs causing sexual urges

10,000 steps myth – should you be a stickler for recommended daily doses?

Why we need to talk about periods, breasts and injuries

Solar drone with wingspan wider than jumbo jet could fly for months

Study Touts Benefit of Mini Nonhormonal IUD — But It’s Not Sold in the U.S.

Negative social ties, like frenemies, could be ageing you

Could Direct Primary Care’s Popularity Be on the Rise?

Will ‘Safe Staffing Committee’ Laws Help Reduce ED Wait Times?

Categories

Archives